Regencell Bioscience Holdings Limited (RGC )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol RGC
- Company Regencell Bioscience Holdings Limited
- Price $14.09
- Changes Percentage 206.3
- Change 9.49
- Day Low $4.34
- Day High $14.84
- Year High $32.44
- Year Low $3.03
- Market Cap $183,351,761
- Price Avg 50 EMA (D) $4.56
- Price Avg 200 EMA (D) $5.68
- Exchange NASDAQ
- Volume 22,740,856
- Average Volume 409,189
- Open $4.34
- Previous Close $4.6
- EPS -0.33
- PE -42.70
- Earnings Announcement 2025-01-24 05:00:00
- Shares Outstanding $13,012,900
Company brief: REGENCELL BIOSCIENCE HOLDINGS LIMITED (RGC )
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Mr. Yat-Gai Au
- https://www.regencellbioscience.com
- HK
- N/A
- 07-16-2021
- KYG7487R1002
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.